Agilent Technologies 6545XT AdvanceBio UHPLC QTOF, biopharmaceutical analysis
Agilent Technologies ·Made in USA · In Active Production

Agilent Technologies 6545XT AdvanceBio UHPLC QTOF, biopharmaceutical analysis

Agilent Technologies 6545XT AdvanceBio UHPLC QTOF, biopharmaceutical analysis — Liquid chromatography mass spectrometry lc ms with Pumping speed 3×10⁻⁵ m³/h.

The 6545XT AdvanceBio is a UHPLC quadrupole time-of-flight LC/MS configured for biopharmaceutical characterization, spanning a 100–10,000 m/z mass range with a Dual Agilent Jet Stream source. It is the AdvanceBio modification of the 6545 QTOF platform, paired with 1290 Infinity II/III LC modules, and is used for intact-protein, peptide-mapping and food-authenticity workflows.

Pumping speed
3×10⁻⁵ m³/h

Agilent Technologies Quadrupole Time Of Flight LC MS Series — Model Comparison & Selection

Model Pumping speed, m³/hMass rangeAcquisition rate, HzAutosampler temperature, °CColumn temperature, °CSample volume, milliliter
6545XT AdvanceBio UHPLC QTOF, biopharmaceutical analysis Current 3×10⁻⁵100...10,0001.04605×10⁻⁴
6560 Ion Mobility QTOF LC/MS, Collision Cross Section 1.6×10⁻⁸100...1,70010445—
Electron capture dissociation for QTOF LCMS of proteins 0.024—15600.01

Full specifications

Core Performance & Functional Specifications
Pumping speed 0.5 mL/min
Acquisition Rate 1.0 spectra/s
Column temperature 60 °C
Gas Flow 12 L/min
Ion source Dual Agilent Jet Stream
Sample Loading Amount 0.6 µg
Sample volume 0.5 µL
Sheath Gas Flow 11 L/min
Solvent A mfr 0.1 water
Solvent B mfr 0.1 % acetonitrile
Nebulizer mfr 60 psig
Quad AMU mfr 500 m/z
Acquisition mode mfr Positive, Extended Mass Range Range
Sample concentration mfr 1.0 μg/μL
Analytical column mfr 2.1 μm
False discovery rate mfr 0.1
LC pump module mfr 1290 Speed
Autosampler module mfr 1290 Multisampler
Needle wash mfr 3 sec
Nebulizer pressure mfr 35 psig
Data acquisition rate mfr 8 spectra/s
Enzyme-to-substrate ratio mfr 1 w/w
Average MS/MS spectra mfr 78683
Average spectra submitted to database matches mfr 8753
Average unique peptides mfr 1084
Average % ID mfr 11.1
Dimensions, Weight & Mechanical Design
Mass range 100...10,000 m/z
Reference mass mfr 922.0098
Deconvoluted mass range mfr 140000...160,000 Daltons
MS1 mass tolerance mfr 10 ppm
MS2 mass tolerance mfr 30 ppm
Peptide length limit mfr 5...60 acids
Isolation width mfr Medium Medium
Electrical, Power & Drive Specifications
Capillary Voltage 5500 V
Nozzle Voltage 2000 V
Fragmentor mfr 380 V
Skimmer mfr 140 V
Operating Conditions, Environment & Protection
Autosampler Temperature 4 °C
Gas Temperature 350 °C
Sheath Gas Temperature 400 °C

Description

Architecture and series positioning

Behavior in biopharmaceutical workflows

LC and autosampler conditions

Integration & Operating Notes

Process Limits
Method settings are workflow-specific, not universal defaults

The documented source and LC settings differ between the intact-mAb and peptide-mapping workflows (for example nebulizer 60 psig vs 35 psig, and 0.6 µg vs 2 µg loading). Treat every value as tied to its method and re-optimize source and gradient conditions when transferring a workflow to a new sample type.

Application notes 5991 7813EN and 5991 8633EN
Control & I/O
Peptide mapping depends on Iterative MS/MS and BioConfirm

The documented peptide-mapping workflow relies on Iterative MS/MS acquisition and MassHunter BioConfirm B.09.00 for processing, with database matching at a 0.1 false discovery rate. Plan the acquisition method and the processing software version together, since the reported identification statistics assume this combination.

Application note 5991 8633EN peptide mapping application
Process Limits
Mass accuracy tolerances constrain calibration and lock mass

The workflows are evaluated at 10 ppm MS1 and 30 ppm MS2 tolerance with a 922.0098 reference mass. Exceeding these tolerances invalidates database-match statistics, so lock-mass stability and calibration must be verified before committing to a peptide-mapping run.

Application note 5991 8633EN peptide mapping application
Maintenance
Needle wash and column hardware are part of the method setup

The documented methods specify a 3-second needle wash and a PLRP-S column for intact-mAb work. These consumables and wash settings are method components rather than base-instrument items, and must be provisioned and configured before the workflow can be reproduced.

Application notes 5991 7813EN and 5991 8633EN

Selection & Integration Q&A

When should I choose the 6545XT AdvanceBio rather than the 6546 or 6560 QTOF?

Pick the 6545XT for biopharmaceutical work needing the 100–10,000 m/z range, such as intact mAb and ADC characterization with deconvoluted masses of 140,000–160,000 Da. The 6546 targets wide dynamic range, and the 6560 adds ion mobility but is specified only to 1,700 m/z.

What LC front end and column does the documented workflow require?

The application notes pair the 6545XT with a 1290 Infinity II UHPLC (1290 pump and multisampler) and a PLRP-S column for intact-mAb work, at 0.5 mL/min and 0.5 µL injection with the autosampler at 4 °C and column at 60 °C. The LC modules are separate from the QTOF.

What source and acquisition conditions must be set for peptide mapping?

The documented peptide-mapping method uses Iterative MS/MS in positive extended mass range, capillary 5500 V, nozzle 2000 V, fragmentor 380 V, skimmer 140 V, sheath gas 11 L/min at 400 °C, drying gas 12 L/min at 350 °C, nebulizer 35 psig, and 15- or 30-minute gradients.

What is not included in the base instrument that the workflows assume?

The workflows assume 1290 Infinity II/III LC modules, a PLRP-S column, MassHunter BioConfirm B.09.00, and the AssayMAP Bravo for sample preparation in the peptide-mapping note. These are separate items and must be provisioned alongside the QTOF.

Dimensional Drawings & Technical Documentation

Technical documentation